Business Context and Reporting Period
Company: Microbot Medical Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 14, 2025
Reporting Period: Events occurring since June 18, 2025.
Key Financial Metrics
This filing reports on a specific capital raise event rather than periodic financial performance. Key metrics include:
- Shares Issued: 1,808,336 shares of common stock.
- Gross Proceeds (Series G): Approximately $1.8 million from the exercise of 1,025,000 options at $1.75 per share.
- Gross Proceeds (Series F): Approximately $1.175 million from the exercise of 783,336 options at $1.50 per share.
- Total Gross Proceeds: Approximately $2.975 million (before deducting placement agent fees and expenses).
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these standard operating metrics.
Material Changes
The primary material change is the increase in outstanding common stock and cash inflow resulting from the exercise of previously outstanding preferred investment options (Series F and Series G). The shares were issued pursuant to Section 4(a)(2) of the Securities Act of 1933 as transactions not involving a public offering.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the registration of the newly issued shares for resale on Form S-3 (Registration Nos. 333-284688 and 333-280113) on behalf of the option holders.
Guidance and Outlook: The filing text does not provide a clear value for future guidance or outlook.
Risks and Contingencies: No specific risks or contingencies are detailed in this excerpt beyond the standard disclosure of unregistered sales.
Investor Verification Checklist
- Verify the exact amount of placement agent fees and expenses deducted from the gross proceeds to determine net cash received.
- Confirm the updated total number of outstanding shares post-issuance.
- Review the specific terms of the Series F and Series G options to understand vesting or future exercise conditions.
- Check the status of the Form S-3 registration statements for resale eligibility.